Work

90.y-Ibritumomab Tiuxetan (Zevalin®) May Enhance Anti-Lymphoma Effect of Reduced-Intensity Fludarabine and Melphalan Regimen in Patients with Relapsed, Refractory B-Cell Non-Hodgkin Lymphoma (NHL) Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT).

Year: 2009

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v114.22.3357.3357

Authors: Auayporn P. Nademanee, Andrew Raubitschek, Joycelynne Palmer, Dave Yamauchi, Maria Delioukina, Leslie Popplewell, Firoozeh Sahebi, Eileen Smith, Anthony Stein, Neil Kogut, Margaret O'Donnell, Stephen J Forman

Institutions: City Of Hope National Medical Center, Kaiser Permanente, City of Hope

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589804864

FWCI:

Cites:

Cited by: 1

Related to: 10